Yang Fan, Liu Can, Liu Xu, Pan Xiandu, Li Xinye, Tian Li, Sun Jiahao, Yang Shengjie, Zhao Ran, An Na, Yang Xinyu, Gao Yonghong, Xing Yanwei
Guang'anmen Hospital, Chinese Academy of Chinese Medical Sciences, Beijing, China.
Beijing University of Chinese Medicine, Beijing, China.
Front Nutr. 2021 Oct 18;8:669325. doi: 10.3389/fnut.2021.669325. eCollection 2021.
Intermittent fasting (IF) has gained attention as a promising diet for weight loss and dysmetabolic diseases management. This systematic review aimed to investigate the effects of IF on cardiometabolic risk factors (CMRFs). A systematic literature search was carried out using three electronic databases, namely PubMed, Embase, and the Cochrane Library, until October 2020. Randomized controlled trials that compared the IF intervention with a control group diet were included. Fourteen effect sizes were expressed as weighted mean difference (WMD) using a fixed-effects model and 95% confidence intervals (CI). Compared to the ones within control groups, participants exposed to the IF intervention reduced their body weight (WMD, -1.78 kg; 95% CI, -2.21 to -1.35; <0.05), waist circumference (WMD, -1.19 cm; 95% CI, -1.8 to -0.57; <0.05), fat mass (WMD, -1.26 kg; 95% CI, -1.57 to -0.95; <0.05), body mass index (WMD, -0.58 kg/m; 95% CI, -0.8 to -0.37; <0.05), systolic blood pressure (WMD, -2.14 mmHg; 95% CI: -3.54 to -0.73; <0.05), diastolic blood pressure (WMD: -1.38 mmHg, 95% CI, -2.35 to -0.41, <0.05), fasting blood glucose (WMD: -0.053 mmol/L; 95% CI: -0.105 to 0.001; <0.05), fasting insulin (WMD, -0.8 mIU/L; 95% CI, -1.15 to -0.44; <0.05), insulin resistance (WMD, -0.21; 95% CI, -0.36 to -0.05; <0.05), total cholesterol (WMD, -0.10 mmol/L; 95% CI, -0.17 to -0.02; <0.05), and triglycerides (WMD, -0.09 mmol/L; 95% CI, -0.13 to -0.04; <0.05). No effects were observed for low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, or glycosylated hemoglobin. This meta-analysis supports the role of IF in improving the component composition of CMRFs, including weight, waist circumference, fat mass, BMI, blood pressure, total cholesterol, triglycerides, fasting insulin, and insulin resistance, compared to a control group diet. Further research on IF interventions should take into account long-term and well-designed administration to draw definitive conclusions.
间歇性禁食(IF)作为一种有前景的减肥和代谢紊乱疾病管理饮食方式已受到关注。本系统评价旨在研究间歇性禁食对心血管代谢危险因素(CMRFs)的影响。使用三个电子数据库,即PubMed、Embase和Cochrane图书馆,进行了系统的文献检索,直至2020年10月。纳入了将间歇性禁食干预与对照组饮食进行比较的随机对照试验。使用固定效应模型和95%置信区间(CI)将14个效应量表示为加权平均差(WMD)。与对照组相比,接受间歇性禁食干预的参与者体重减轻(WMD,-1.78 kg;95%CI,-2.21至-1.35;P<0.05)、腰围减小(WMD,-1.19 cm;95%CI,-1.8至-0.57;P<0.05)、脂肪量减少(WMD,-1.26 kg;95%CI,-1.57至-0.95;P<0.05)、体重指数降低(WMD,-0.58 kg/m²;95%CI,-0.8至-0.37;P<0.05)、收缩压降低(WMD,-2.14 mmHg;95%CI:-3.54至-0.73;P<0.05)、舒张压降低(WMD:-1.38 mmHg,95%CI,-2.35至-0.41,P<0.05)、空腹血糖降低(WMD:-0.053 mmol/L;95%CI:-0.105至0.001;P<0.05)、空腹胰岛素降低(WMD,-0.8 mIU/L;95%CI,-1.15至-0.44;P<0.05)、胰岛素抵抗降低(WMD,-0.21;95%CI,-0.36至-0.05;P<0.05)、总胆固醇降低(WMD,-0.10 mmol/L;95%CI,-0.17至-0.02;P<0.05)和甘油三酯降低(WMD,-0.09 mmol/L;95%CI,-0.13至-0.04;P<0.05)。未观察到对低密度脂蛋白胆固醇、高密度脂蛋白胆固醇或糖化血红蛋白有影响。该荟萃分析支持间歇性禁食在改善心血管代谢危险因素的组成成分方面的作用,与对照组饮食相比,这些成分包括体重、腰围、脂肪量、体重指数、血压、总胆固醇、甘油三酯、空腹胰岛素和胰岛素抵抗。关于间歇性禁食干预的进一步研究应考虑长期且设计良好的给药方式以得出明确结论。